After being diagnosed with stage 3C breast cancer, retired teacher Janet Fuller sought a treatment approach that aligned with ...
Dr. Jeremy Hollis talks with John Higgins about the two molecular mysteries that he solved on the way to earning his ...
T-cell acute lymphoblastic leukemia (ALL) is a less common subtype of acute lymphoblastic leukemia. It happens more often in adults than in children. T-cell ALL starts in immature cells that would ...
Graced with good weather and even better science, the 2026 International Invasive Lobular Carcinoma (ILC) Symposium, held ...
Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...
A new five-year funding award led by Fred Hutch physician and stem cell transplant expert Mohamed Sorror, MD, MS, from the Patient-Centered Outcomes Research Institute (PCORI) will support three ...
As wildfire smoke fills the skies from Seattle to Spain, public health researchers at Fred Hutch Cancer Center are sharing tools they hope will help people in the Pacific Northwest (and beyond) ...
Seattle — July 28, 2026 —In a landmark study published in Nature Medicine, an international team of researchers have identified new genetic risk factors associated with fibromyalgia syndrome.
Staging means finding out how far cancer has spread in your body. Different types of leukemia are assessed in different ways, and some are not staged. There is no standard staging system that applies ...
Three months after Mike Cleek hurt his hip running, after physical therapy didn’t leave him feeling better and time didn’t ease the pain, he made an appointment with an orthopedist. He had switched ...
Watch out, metastatic ER+/HER2- breast cancer. There’s a new targeted agent in town. On Tuesday, the U.S. Food and Drug Administration approved the drug gedatolisib, a multi-targeted kinase inhibitor ...
Eight Fred Hutch researchers receive nearly $1 million to advance projects with industry partnership potential SEATTLE — July 14, 2026 — Eight researchers at Fred Hutch Cancer Center will receive a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results